Omama Zubairi Pharm D, R Ph
About Omama Zubairi Pharm D, R Ph
Omama Zubairi, Pharm D, R Ph, is the Senior Manager of US Franchise Medical Services at Bristol Myers Squibb, with extensive experience in oncology and immuno-oncology medical affairs.
Company
Omama Zubairi is currently employed at Bristol Myers Squibb. Bristol Myers Squibb is a global biopharmaceutical company focused on the discovery, development, and delivery of innovative medicines. In her role, she is involved in US Franchise Medical Services, contributing to various medical and scientific initiatives within the company.
Title
Omama Zubairi holds the position of Senior Manager, US Franchise Medical Services at Bristol Myers Squibb. This role involves oversight and management of medical services, ensuring that strategies and operations align with the company's goals and standards in the United States.
Education and Expertise
Omama Zubairi earned her Doctor of Pharmacy (PharmD) degree from Rutgers University-New Brunswick. Her academic and professional background is deeply rooted in pharmacy, with specialized expertise in oncology and immuno-oncology medical affairs. This blend of rigorous education and hands-on experience positions her as a knowledgeable professional in her field.
Previous Roles
Before her current role, Omama Zubairi amassed diverse experience in several notable positions. She served as a US Franchise Medical Scientist at Bristol Myers Squibb and as a US Medical Affairs Oncology Manager at Daiichi Sankyo, Inc. Additionally, she completed a post-doctoral fellowship in Global Oncology Medical Affairs at Daiichi Sankyo. Her early career includes roles as a Medical Information - Metabolics Extern at Janssen Inc., a Pharmacy Intern at Walgreens, and a PharmD WWMC Immuno-Oncology Intern at Bristol-Myers Squibb.
Professional Experience in Medical Affairs
Omama Zubairi’s professional journey highlights significant contributions to medical affairs in both oncology and immuno-oncology. Her roles at companies like Bristol Myers Squibb and Daiichi Sankyo have allowed her to develop substantial expertise in these specialties, making her a valuable asset in medical communications and strategic medical services.